142 related articles for article (PubMed ID: 19573298)
21. Huntington Disease: Molecular Diagnostics Approach.
Bastepe M; Xin W
Curr Protoc Hum Genet; 2015 Oct; 87():9.26.1-9.26.23. PubMed ID: 26439718
[TBL] [Abstract][Full Text] [Related]
22. Advances in huntington disease drug discovery: novel approaches to model disease phenotypes.
Bard J; Wall MD; Lazari O; Arjomand J; Munoz-Sanjuan I
J Biomol Screen; 2014 Feb; 19(2):191-204. PubMed ID: 24196395
[TBL] [Abstract][Full Text] [Related]
23. Weight loss in Huntington disease increases with higher CAG repeat number.
Aziz NA; van der Burg JM; Landwehrmeyer GB; Brundin P; Stijnen T; ; Roos RA
Neurology; 2008 Nov; 71(19):1506-13. PubMed ID: 18981372
[TBL] [Abstract][Full Text] [Related]
24. Making (anti-) sense out of huntingtin levels in Huntington disease.
Evers MM; Schut MH; Pepers BA; Atalar M; van Belzen MJ; Faull RL; Roos RA; van Roon-Mom WM
Mol Neurodegener; 2015 Apr; 10():21. PubMed ID: 25928884
[TBL] [Abstract][Full Text] [Related]
25. Oxidative stress causes DNA triplet expansion in Huntington's disease mouse embryonic stem cells.
Jonson I; Ougland R; Klungland A; Larsen E
Stem Cell Res; 2013 Nov; 11(3):1264-71. PubMed ID: 24041806
[TBL] [Abstract][Full Text] [Related]
26. Null alleles at the Huntington disease locus: implications for diagnostics and CAG repeat instability.
Williams LC; Hegde MR; Nagappan R; Faull RL; Giles J; Winship I; Snow K; Love DR
Genet Test; 2000; 4(1):55-60. PubMed ID: 10794362
[TBL] [Abstract][Full Text] [Related]
27. Age-dependent and tissue-specific CAG repeat instability occurs in mouse knock-in for a mutant Huntington's disease gene.
Ishiguro H; Yamada K; Sawada H; Nishii K; Ichino N; Sawada M; Kurosawa Y; Matsushita N; Kobayashi K; Goto J; Hashida H; Masuda N; Kanazawa I; Nagatsu T
J Neurosci Res; 2001 Aug; 65(4):289-97. PubMed ID: 11494364
[TBL] [Abstract][Full Text] [Related]
28. CAG expansion in the Huntington disease gene is associated with a specific and targetable predisposing haplogroup.
Warby SC; Montpetit A; Hayden AR; Carroll JB; Butland SL; Visscher H; Collins JA; Semaka A; Hudson TJ; Hayden MR
Am J Hum Genet; 2009 Mar; 84(3):351-66. PubMed ID: 19249009
[TBL] [Abstract][Full Text] [Related]
29. Analysis of triplet repeats in the huntingtin gene in Japanese families affected with Huntington's disease.
Masuda N; Goto J; Murayama N; Watanabe M; Kondo I; Kanazawa I
J Med Genet; 1995 Sep; 32(9):701-5. PubMed ID: 8544189
[TBL] [Abstract][Full Text] [Related]
30. Autopsy-proven Huntington's disease with 29 trinucleotide repeats.
Kenney C; Powell S; Jankovic J
Mov Disord; 2007 Jan; 22(1):127-30. PubMed ID: 17115386
[TBL] [Abstract][Full Text] [Related]
31. Huntington disease in subjects from an Israeli Karaite community carrying alleles of intermediate and expanded CAG repeats in the HTT gene: Huntington disease or phenocopy?
Herishanu YO; Parvari R; Pollack Y; Shelef I; Marom B; Martino T; Cannella M; Squitieri F
J Neurol Sci; 2009 Feb; 277(1-2):143-6. PubMed ID: 19059613
[TBL] [Abstract][Full Text] [Related]
32. Novel BAC Mouse Model of Huntington's Disease with 225 CAG Repeats Exhibits an Early Widespread and Stable Degenerative Phenotype.
Wegrzynowicz M; Bichell TJ; Soares BD; Loth MK; McGlothan JS; Mori S; Alikhan FS; Hua K; Coughlin JM; Holt HK; Jetter CS; Pomper MG; Osmand AP; Guilarte TR; Bowman AB
J Huntingtons Dis; 2015; 4(1):17-36. PubMed ID: 26333255
[TBL] [Abstract][Full Text] [Related]
33. Selective degeneration in YAC mouse models of Huntington disease.
Van Raamsdonk JM; Warby SC; Hayden MR
Brain Res Bull; 2007 Apr; 72(2-3):124-31. PubMed ID: 17352936
[TBL] [Abstract][Full Text] [Related]
34. Huntington Disease as a Neurodevelopmental Disorder and Early Signs of the Disease in Stem Cells.
Wiatr K; Szlachcic WJ; Trzeciak M; Figlerowicz M; Figiel M
Mol Neurobiol; 2018 Apr; 55(4):3351-3371. PubMed ID: 28497201
[TBL] [Abstract][Full Text] [Related]
35. Wild type Huntingtin reduces the cellular toxicity of mutant Huntingtin in mammalian cell models of Huntington's disease.
Ho LW; Brown R; Maxwell M; Wyttenbach A; Rubinsztein DC
J Med Genet; 2001 Jul; 38(7):450-2. PubMed ID: 11432963
[TBL] [Abstract][Full Text] [Related]
36. [Genetic diagnosis of Huntington disease].
Mo YQ; Li LY; Lu GX
Yi Chuan; 2005 Nov; 27(6):861-4. PubMed ID: 16378928
[TBL] [Abstract][Full Text] [Related]
37. Expanding the Spectrum of Genes Involved in Huntington Disease Using a Combined Clinical and Genetic Approach.
Mariani LL; Tesson C; Charles P; Cazeneuve C; Hahn V; Youssov K; Freeman L; Grabli D; Roze E; Noël S; Peuvion JN; Bachoud-Levi AC; Brice A; Stevanin G; Durr A
JAMA Neurol; 2016 Sep; 73(9):1105-14. PubMed ID: 27400454
[TBL] [Abstract][Full Text] [Related]
38. Accurate determination of the number of CAG repeats in the Huntington disease gene using a sequence-specific internal DNA standard.
Bruland O; Almqvist EW; Goldberg YP; Boman H; Hayden MR; Knappskog PM
Clin Genet; 1999 Mar; 55(3):198-202. PubMed ID: 10334474
[TBL] [Abstract][Full Text] [Related]
39. The impairment of cholesterol metabolism in Huntington disease.
Leoni V; Caccia C
Biochim Biophys Acta; 2015 Aug; 1851(8):1095-105. PubMed ID: 25596342
[TBL] [Abstract][Full Text] [Related]
40. Enhanced Detection and Sizing of the HTT CAG Repeat Expansion in Huntington Disease Using an Improved Triplet-Primed PCR Assay.
Zhao M; Lee CG; Law HY; Chong SS
Neurodegener Dis; 2016; 16(5-6):348-51. PubMed ID: 27207688
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
